The New York Times
BREAKING NEWS
A Pfizer-BioNTech trial found the vaccine extremely effective in 12- to 15-year-olds, with no coronavirus infections among children who received it.
Wednesday, March 31, 2021 6:46 AM EST
The findings, if they hold up, may speed a return to normalcy for millions of American families.
Depending on regulatory approval, vaccinations could begin before the start of the next academic year for middle school and high school students, and for elementary school children not long after.